Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH
Top

17-03-2015 | Staging | Book chapter | Article

23. Classification of Adult Renal Tumors and Grading of Renal Cell Carcinoma

Authors: William R. Sukov, MD, John C. Cheville, MD

Publisher: Springer New York

Login to get access

Abstract

There are many types of renal tumors, both benign and malignant, that affect the adult kidney. This chapter covers the International Society of Urologic Pathology classification of adult renal tumors including recently described variants as well as grading of renal cell carcinoma. The pathology, immunohistochemistry, and cytogenetic findings of adult renal tumors are discussed.
Literature
1.
Kovacs G, Akhtar M, Beckwith JB, et al. The Heidelberg classification of renal cell carcinoma. J Pathol. 1997;183:131–3.CrossRefPubMed
2.
Storkel S, Eble JN, Adlakha K, et al. Classification of renal cell carcinoma workgroup No. 1 Union Internationale Contre Cancer (UICC) and American Joint Committee on Cancer (AJCC). Cancer. 1997;80:987–9.CrossRefPubMed
3.
Srigley JR, Delahunt B, Eble JN, et al. The International Society of Urological Pathology (ISUP) vancouver classification of renal neoplasia. Am J Surg Pathol. 2013;37:1469–89.CrossRefPubMed
4.
Skinner DG, Colvin RB, Vermillion CD, et al. Diagnosis and management of renal cell carcinoma: a clinical and pathologic study of 309 cases. Cancer. 1981;28:1165–77.CrossRef
5.
Fuhrman AS, Lasky LC, Limas C, et al. Prognostic significance in morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982;6:656–63.CrossRef
6.
Delahunt B, Chevill JC, Martignoni G, et al. The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol. 2013;37:1490–1504.CrossRefPubMed
7.
Delahunt B, McKenney JK, Lohse CM, et al. A novel grading system for clear cell renal cell carcinoma incorporating tumor necrosis. Am J Surg Pathol. 2013;37:311–22.CrossRefPubMed
8.
Tumors of the kidney. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA, editors. Pathology and genetics. Tumors of the urinary system and male genital organs. Lyon: IARC Press; 2004. pp. 9–87.
9.
Al-Ahmadie HA, Alden D, Fine SW, et al. Role of immunohistochemistry in adult renal tumors: an ex vivo study. Am J Surg Pathol. 2011;35:949–61.CrossRefPubMed
10.
Cheville JC, Lohse CM, Zincke H, et al. Comparison of outcomes and prognostic features among the histological subtypes of renal cell carcinoma. Am J Surg Pathol. 2003;27:612–24.CrossRefPubMed
11.
Lohse CM, Cheville JC. A review of prognostic pathologic features and algorithms for patients treated surgically for renal cell carcinoma. Clin Lab Med. 2005;25:433–64.CrossRefPubMed
12.
Leibovich BC, Lohse CM, Crispen PL, et al. Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. J Urol. 2010;183:1309–15.CrossRefPubMed
13.
Delahunt B, Eble JN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 cases. Mod Pathol. 1997;10:537–44.PubMed
14.
Sukov WR, Lohse CM, Leibovich BC, et al. Clinical and pathological features associated with prognosis in patients with papillary renal cell carcinoma. J Urol. 2011;187:54–9.CrossRefPubMed
15.
Williamson SR, Eble JN, Cheng L, Grignon DJ. Clear cell papillary renal cell carcinoma: differential diagnosis and extended immunohistochemical profile. Mod Pathol. 2013;26:697–708.CrossRefPubMed
16.
Elwood H, Chaux A, Schultz L, et al. Immunohistochemical analysis of SMARCB1/INI-1 expression in collecting duct carcinoma. Urology. 2011;78(474):e1–5.
17.
Davis CJ, Mostofi FK, Sesterhenn IA. Renal medullary carcinoma: the seventh sickle syndrome. Am J Surg Pathol. 1995;19:1–11.CrossRefPubMed
18.
Crispen PL, Tabidian MR, Almer C, et al. Unclassified renal cell carcinoma: impact on survival following nephrectomy. Urology. 2010;76:580–6.CrossRefPubMed
19.
Fine SW, Argani P, DeMarzo A, et al. Expanding the histologic spectrum of mucinous tubular and spindle cell carcinoma of the kidney. Am J Surg Pathol. 2006;30:1154–60.
20.
Rakozy C, Schmahl GE, Bogner S, Storkel S. Low-grade tubular-mucinous renal neoplasms: morphologic, immunohistochemical and genetic features. Mod Pathol. 2002;15:1162–71.CrossRefPubMed
21.
Amin BM, MacLennan GT, Gupta R, et al. Tubulocystic carcinoma of the kidney. Clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma. Am J Surg Pathol. 2009;33:384–92.CrossRefPubMed
22.
Ellis CL, Elbe JN, Subhawong AP, et al. Clinical heterogeneity of Xp11 translocation renal cell carcinoma: impact of fusion subtype, age and stage. Mod Pathol. 2014;27(6):875–86.CrossRefPubMed
23.
Argani P, Olgac S, Tickoo SK, et al. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic and genetic spectrum. Am J Surg Pathol. 2007;31:1149–60.CrossRefPubMed
24.
Amin MB, Gupta R, Ondrej H, et al. Primary thyroid-like follicular carcinoma of the kidney: report of 6 cases of a histologically distinctive adult renal epithelial neoplasm. Am J Surg Pathol. 2009;33:393–400.CrossRefPubMed
25.
Davis CJ Jr., Barton JH, Sesterhenn IA, et al. Metanephric adenoma. Clinico-pathologic study of fifty patients. Am J Surg Pathol. 1995;19:1101–14.CrossRefPubMed
26.
Eble JN, Amin MB, Young RH. Epithelioid angiomyolipoma of the kidney: a report of five cases with a prominent and diagnostically confusing epithelioid smooth muscle component. Am J Surg Pathol. 1997;21:1123–30.CrossRefPubMed
27.
He W, Cheville JC, Sadow PM, et al. Epithelioid angiomyolipoma of the kidney: pathologic features and clinical outcome in a series of consecutively resected tumors. Mod Pathol. 2013;26:1355–64.CrossRefPubMed
28.
Turbiner J, Amin MB, Humphrey PA, et al. Cystic nephroma and mixed epithelial and stromal tumor of the kidney: a detailed clinico-pathologic analysis of 34 cases and proposal for renal epithelial and stromal tumor (REST) as a unifying term. Am J Surg Pathol. 2007;31:489–500.CrossRefPubMed
  • » This content is intended only for healthcare providers and was made possible by educational funding provided by F. Hoffmann-La Roche Ltd.
Image Credits